Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways

The Journal of Allergy and Clinical Immunology, 05/01/2012

Imidazoquinolines (IMQs) Toll–like receptor (TLR)8 agonists engage adenosine–refractory TLR8 and inflammasome pathways to induce robust monocyte and monocyte–derived dendritic cells (MoDCs) activation and represent promising neonatal adjuvants.

Print Article Summary Cat 2 CME Report